Breadcrumb

Healthcare Inspection – Lack of Follow-Up Care for Positive Colorectal Cancer Screening, New Mexico VA Health Care System, Albuquerque, New Mexico

Report Information

Issue Date
Report Number
15-00018-349
VISN
State
New Mexico
District
VA Office
Veterans Health Administration (VHA)
Report Author
Office of Healthcare Inspections
Report Type
Hotline Healthcare Inspection
Recommendations
4
Questioned Costs
$0
Better Use of Funds
$0
Congressionally Mandated
No

Summary

Summary
OIG conducted an inspection in response to allegations concerning the lack of follow-up care for patients with positive colorectal cancer screening at the New Mexico VA Health Care System (facility), Albuquerque, NM. We did not substantiate that laboratory staff had a list of 300 patients who had tested positive for fecal occult blood, but no follow-up had been done. We determined that laboratory personnel do not keep lists of patients with positive fecal occult results. However, we found that laboratory staff flagged positive results in patients’ electronic health records which generated a “view alert” to providers and that providers did not consistently notify patients of positive fecal immunochemical tests (used to determine presence of occult blood) in fiscal years (FYs) 2013 and 2014. As a result, some patients did not receive timely follow-up care. We identified nine patients diagnosed with colorectal cancer who experienced delays and, in some instances, significant delays that may have affected the patients’ clinical outcomes. Such delays placed patients at unnecessary risk for adverse outcomes. We determined that during FY 2013 and FY 2014, the facility did not have a process in place to monitor provider compliance with colorectal cancer screening. In 2012, facility leaders assigned a registered nurse to follow up on positive fecal immunochemical tests and report to the Chief of Staff monthly. However, the employee transferred from the facility, and the position had been vacant for over 2 years. We found that facility leaders did not institute processes for monitoring provider compliance with colorectal cancer screening and reporting to ensure that patients received timely notification of results and appropriate follow-up care. We made four recommendations.

Open Recommendation Image, SquareOpenClosed and Implemented Recommendation Image, CheckmarkClosed-ImplementedNot Implemented Recommendation Image, X character'Closed-Not Implemented
No. 1
Closed and Implemented Recommendation Image, Checkmark
to Veterans Health Administration (VHA)
We recommended that the Facility Director ensure that all patients who experienced delays in notifications of positive fecal immunochemical tests are assessed to determine if appropriate follow-up care was rendered and whether the delays adversely affected the patients¿ clinical outcomes.
No. 2
Closed and Implemented Recommendation Image, Checkmark
to Veterans Health Administration (VHA)
We recommended that the Facility Director confer with the Office of Chief Counsel (formerly known as Regional Counsel) regarding the care of the four patients described in this report and any additional patients identified in further review who may have been adversely affected, to determine the appropriate action to take, if any.
No. 3
Closed and Implemented Recommendation Image, Checkmark
to Veterans Health Administration (VHA)
We recommended that the Facility Director ensure that providers communicate positive colorectal cancer screening results to patients and document notifications in electronic health records according to Veterans Health Administration test notification policy.
No. 4
Closed and Implemented Recommendation Image, Checkmark
to Veterans Health Administration (VHA)
We recommended that the Facility Director ensure that processes are in place to monitor providers’ compliance with Veterans Health Administration colorectal cancer screening policy.